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136 Poster Session-IITLR signaling and AM function, we sought to determine whether
IRAK-M was involved in PGE2-induced immunosuppression post-
BMT.
Methods: IRAK-M protein and mRNA expression were mea-
sured in AMs from control and BMT mice. Additionally, control
AMs cultured in the presence or absence of 100 nM PGE2 were an-
alyzed for IRAK-M expression. To study the role of IRAK-M post-
BMT, we transplanted either wild-type (WT) BM or IRAK-M-/-
BM into WT recipients. Levels of PGE2 were measured in AMs
five weeks post-BMT. BMT and control mice were also challenged
with P. aeruginosa infection and bacterial burden was measured in
the lung and blood 24 hours later.
Results: BMT AMs displayed elevated IRAK-M expression rela-
tive to non-transplant control AMs. Treatment of control AMs with
PGE2 upregulated IRAK-MmRNA and protein expression. Despite
overproduction of PGE2, IRAK-M-/-.WT BMT mice displayed
improved host defense against P. aeruginosa lung infection com-
pared to WT.WT BMT mice.
Conclusions: PGE2 may impair host defense against P. aerugi-
nosa in BMT AMs via upregulation IRAK-M. Strategies to limit
IRAK-M elevation post-BMT may prove efficacious in limiting in-
fections post-BMT.380
PLASMACYTOID CD1231 DENDRITIC CELL RECOVERY AND REDUCED
ACTIVATION STATE OF CIRCULATING CD81 T CELLS PREDICT SURVIVAL
AFTER UNRELATED CORD BLOOD TRANSPLANT (UCBT)
Wilfret, D.A.1, Mendizabal, A.M.2, Reese, M.1, Vinesett, R.1,
Kurtzberg, J.1, Szabolcs, P.1,3 1Duke University, Durham, NC; 2The
EMMES Corporation, Rockville, MD; 3Duke University, Durham, NC
Background: Reconstitution of adaptive immunity is critical for
long term survival following HCT. UCBT is a suitable option for
those who lack HLA-matched sibling donors. Antigen presenting
dendritic cells (DC) and lymphocytes are critical for acquiring pro-
tective immunity. Infections remain the major cause of TRM. In
the COBLT study, successful recovery of antiviral cellular immunity
was associated with a reduced rate of relapse.
Methods: Between July 2005, and December 2007, 95 children
with full donor chimerism following myeloablative conditioning
and a single cord UCBT were assessed for reconstitution of DC
andT cell subsets, B andNK cells at 3, 6, 12, 24, and 36months after
UCBT to analyze their impact on overall survival (OS).
Results: 52 and 43 children were transplanted for non-malig-
nant and malignant diseases, respectively. The median age was
2.7 years, 55 patients were male, 38 (40%) were 4/6, 39 (41%)
were 5/6 and 18 (19%) were 6/6 HLA match. The median in-
fused TNC and CD341 cell dose was 7.2  107/kg and 1.9 
105/kg, respectively. Of the 95 patients, 6 died before day 180,
11 died between day 180 and 365 [1-year survival probability
81.7% (95% CI 72.2%-88.2%)], and 8 died between day 365
and 730 [2-year survival probability 69.1% (95% CI 57.1%-
78.3%)]. In an univariate analysis of OS post-transplant, non-ma-
lignant diagnosis (HR 5 0.25, p 5 0.001), HLA match of 5/6 or
6/6 (HR 5 0.41, p 5 0.02), absolute number of CD1231 ‘‘plas-
macytoid’’ dendritic cells (pDC) .8 cells/ul (HR 5 42, p 5
0.04), %CD45RA1/CD62L1 ‘‘recent thymic emigrants’’ .13%
(HR 5 0.41, p 5 0.02), %HLA-DR1/CD81 T cells \19%
(HR 5 0.25, p 5 0.01) were each associated with a decreased
risk of death, while ‘‘myeloid’’ DC and other lymphocyte recovery
had no statistical impact. In this cohort where all studied patients
have successfully engrafted, gender, race, CMV serology, TNC,
CD341 cell dose, and TBI had no impact. In multivariate
models non-malignant disease remained a predictor for better
OS. (HR 5 0.27, p 5 0.002). Two immune parameters remained
significant predictors of survival when patient and graft specific
variables were included in multivariate analysis; abs# of
CD1231 pDC .8 cells / ul (p 5 0.05) and %HLA-DR1/
CD81 T cells \19% (p 5 0.01).
Conclusion: This is the first analysis to suggest that the absolute
number of CD1231 pDC .8 Cells /ul is an independent predictor
of survival after UCBT. Independently, lower activation state of
CD81 T cells also correlates with superior survival.Table 1. Univariate andmultivariate analysis of overall survival
(OS).
Hazard Ratio P-valueUnivariate Model
GenderFemale 1.52 0.3
Male 1.00Disease
Non-Malignant 0.25 0.001
Malignant 1.00Cell Doses
TNC / kg 1.03 0.4
CD341 / kg 1.01 0.9HLA Match
5 / 6 or 6 / 6 0.41 0.02
4 / 6 1.00Cell Type
Absolute Number of CD1231DC (pDC / ul) 0.42 0.04
CD45RA1/CD62L1 ‘‘Recent Thymic
Emigrants’’ .13%0.41 0.02%HLA-DR1/CD81 T cells\19% 0.25 0.01
Multivariate ModelDisease
Non-Malignant 0.27 0.002
Malignant 1.00HLA Match
5 / 6 or 6 / 6 0.53 0.1
4 / 6 1.00Cell Type
Absolute Number of CD1231 (pDC / ul) 0.44 0.05
HLA-DR1/CD81 T Cells\19% 0.29 0.01381
HOMEOSTATIC MECHANISMS AFFECT RECONSTITUTION OF CD41
FOXP31 REGULATORY T CELLS AFTER HEMATOPOIETIC STEM CELL
TRANSPLANTATION
Matsuoka, K.-i., Kim, H.T., McDonough, S., Herrera, M., Cutler, C.S.,
Koreth, J., Reynolds, C., Antin, J.H., Soiffer, R.J., Ritz, J. Dana-Farber
Cancer Institute, Harvard Medical School, Boston, MA
CD41FoxP31 regulatory T cells (Treg) play a critical role in im-
mune tolerance after allogeneic HSCT but the homeostatic mecha-
nisms that affect Treg reconstitution post-HSCT have not been
identified. To address this issue we simultaneously examined pheno-
typic and functional characteristics of Treg and CD41FoxP3- con-
ventional T cells (Tcon) in peripheral blood after allogeneic HSCT
(n 5 16, median 10 months post-HSCT). Post-HSCT Treg ex-
pressed higher levels of mitotic marker Ki-67 than Tcon (median
5.2% vs 1.5%; p\0.0001) and Treg from normal donors (median
5.2% vs 2.5%; p 5 0.03). %Ki-671 Treg was inversely correlated
with peripheral CD4 count (r5 -0.86, p\0.0001). To assess survival
of Treg, we purified 4 different CD41 T cell subsets by cell sorting
(CD45RA1 Tcon, CD45RA- Tcon, CD45RA1 Treg and
CD45RA- Treg) from 4 healthy donors, 8 patients post-autologous
and 8 post-allogeneicHSCT. Each subset was cultured with or with-
out agonistic FAS antibody and apoptosis was measured using An-
nexin-V staining. Anti-FAS rapidly induced apoptosis of
CD45RA- Treg from patients (median 25.3%) while all other
Treg and Tcon (median 4.5%, p\0.0001) subsets were relatively re-
sistant to apoptosis. The degree of memory CD45RA- Treg apopto-
sis is equivalent after autologous and allogeneicHSCT, but inversely
correlated with the peripheral lymphocyte count in the patient (r 5
-0.54, p 5 0.03). The effect of lymphopenia was also evaluated by
prospectively monitoring Treg and Tcon recovery 3–24 months
post-HSCT in 46 patients who received peripheral stem cell grafts
from HLA-identical donors after myeloablative conditioning. In
27 patients with .220/ul CD4 T cells at 6 months, both Tcon and
Treg gradually increased over the subsequent 18 months. In con-
trast, in 19 patients with\220/ul CD4 T cells at 6 months, Tcon
gradually increased but Treg decreased over the subsequent 12–24
months. These results indicate that Treg reconstitution is character-
ized by increased peripheral proliferation but this is counterbalanced
by increased sensitivity to apoptosis. These characteristics are more
